This company makes reliable diagnostic tests for COVID-19 along with other infectious diseases like Zika and tuberculosis.
This stock has very exciting growth potential if the FDA grant EUA approval (pending review) for their direct saliva test technology.
It will make routine testing more accessible, more efficient, faster
Fingers crossed!
under valued shares are lower than when they lost money.
now no debt and making millions .
keep buying
1 Like
Keeping eye on it timbo